injected with streptozotocin immediately after surgery.
In non-diabetic rats, PTH administration significantly increased renal 1,25(OH)2D3 production (11 \m=+-\2 vs 46 \ m=+-\5 pg/min/g; P < 0.05). In diabetic rats, however, PTH caused only a modest increase in 1,25(OH)2D3 production (11 \m=+-\1 vs 19 \m=+-\ 4 pg/min/g; P < 0.05). With insulin replacement, PTH stimulation of 1,25(OH)2D3 production was markedly increased over that seen in diabetic rats (48 \m=+-\12 vs 19 \ m=+-\4 pg/min/g; P < 0.05). PTH was equally effective in raising serum calcium, depressing serum phosphorus and tubular reabsorption of phosphate in non-diabetic as well as in diabetic rats.
These results demonstrate that insulin is necessary for the maximal stimulation of renal 1,25(OH)2D3 production by PTH. However, insulin is not necessary for PTH action in terms of renal handling of phosphate and inducing hypercalcaemia. These results suggest multiple pathways for the action of PTH, only some of which are insulin requiring.
Previous studies have shown that plasma levels of 1,25-dihydroxyvitamin D3 (l,25(OH)2D3), the biologically active form of vitamin D3, are low in diabetic rats (Schneider et al. 1977; Horst et al. 1979; Hough et al. 1982) . The catabolism of l,25(OH)2Û3 in diabetic rats is not accelerated (Spencer et al. 1980) suggesting a decrease in the production rate. Recently, we have found that there is an impairment in renal production of l,25(OH)2D3 in diabetes and this impairment is corrected by insulin treatment (Wongsurawat et al. 1983 ).
One of the major regulators of the renal produc¬ tion of l,25(OH)2D3 is the parathyroid hormone (PTH) (Garabedian et al. 1972; Henry et al. 1974). Thyroparathyroidectomy has been shown to mar¬ kedly reduce renal l,25(OH)2Ü3 production (Gara¬ bedian et al. 1972 (Schneider et al. 1974 ). However, presence of insulin seems to be an important factor for PTH stimulation of renal l,25(OH)2D3 produc¬ tion (Henry 1981 (Fig. 1 ). The precise mechanism by which PTH modulates renal 250HD3 metabolism is unknown, but some evidence has been presented for the involvement of adenylate cyclase, cyclic AMP and protein kinase activity (Horiuchi et al. 1977; Rost et al. 1981; Armbrecht et al. 1984) . Renal resistance to PTH in streptozotocin-induced diabetic rats has been suggested as the mechanism by which the la-hydroxylase is depressed (Sulimovici et al. 1981) . This was based on the finding that the diabetic rats excreted significantly less nephrogenous cyclic AMP compared with the control or the insulin-treated diabetics. However, the kidneys of streptozotocin-induced diabetic rats elicited a nor¬ mal cyclic AMP response to PTH (Wongsurawat et al. 1983 (Srivastava 1983 (Srivastava 1983 (Armbrecht et al. 1981b ). It may be that in both diabetes and aging there is a biochemical defect distal to the generation of cyclic AMP which affects l,25(OH)2D3 production but does not affect renal handling of calcium and phosphorus.
